Evolution of poliovirus type 1 during 5.5 years of prolonged enteral replication in an immunodeficient patient

Virology

Volumn 265, Issue 2, 1999, Pages 178-184

  Bellmunt, Andreas ^a   May, Günter ^b   Zell, Roland ^c   Pring Åkerblom, Patricia ^a   Verhagen, Willem ^a   Heim, Albert ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; DNA FLANKING REGION; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARESIS; POLIOMYELITIS VIRUS 1; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS SHEDDING;

HUMAN POLIOVIRUS 1; POLIOVIRUS; POLIOVIRUS 1; RNA VIRUSES;

EID: 0033590219     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0003     Document Type: Article

References (21)

1. World Health Organization (WHO), 1997, Manual for the Virologic Investigation of Poliomyelitis. WHO/EPI/GEN/97.1, Geneva, Switzerland.
2. Alexander J. P. Jr., Gary H. E. Jr., Pallansch M. A. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: A review of the literature. J. Infect. Dis. 175:1997;S176-182.
3. Balanant J., Guillot S., Candrea A., Delpeyroux F., Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology. 184:1991;645-654.
4. Bouchard M. J., Lam D. H., Racaniello V. R. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J. Virol. 69:1995;4972-4978.
5. Christodoulou C., Colbere-Garapin F., Macadam A., Taffs L. F., Marsden S., Minor P., Horaud F. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J. Virol. 64:1990;4922-4929.
6. Dowdle W. R., Birmingham M. E. The biologic principles of poliovirus eradication. J. Infect. Dis. 175:1997;S286-292.
7. PHYLIP - Phylogeny Inference Package, Version, 3.5c. 1995, Department of Genetics, University of Washington, Seattle.
8. Georgescu M. M., Balanant J., Macadam A., Otelea D., Combiescu M., Combiescu A. A., Crainic R., Delpeyroux F. Evolution of the Sabin type 1 poliovirus in humans: Characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 71:1997;7758-7768.
9. Kew O. M., Sutter R. W., Nottay B. K., McDonough M. J., Prevots D. R., Quick L., Pallansch M. A. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J. Clin. Microbiol. 36:1998;2893-2899.
10. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:1980;111-120.
11. McGoldrick A., Macadam A. J., Dunn G., Rowe A., Burlison J., Minor P. D., Meredith J., Evans D. J., Almond J. W. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J. Virol. 69:1995;7601-7605.
12. Minor P. D. Antigenic structure of poliovirus. Microbiol. Sci. 3:1986;141-144.
13. Mulders M. N., Lipskaya G. Y., van der Avoort H. G., Koopmans M. P., Kew O. M., van Loon A. M. Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J. Infect. Dis. 171:1995;1399-1405.
14. Rico-Hesse R., Pallansch M. A., Nottay B. K., Kew O. M. Geographic distribution of wild poliovirus type 1 genotypes. Virology. 160:1987;311-322.
15. Ryder R. W., Oxtoby M. J., Mvula M., Batter V., Baende E., Nsa W., Davachi F., Hassig S., Onorato I., Deforest A. Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J. Pediatr. 122:1993;697-702.
16. Skinner M. A., Racaniello V. R., Dunn G., Cooper J., Minor P. D., Almond J. W. New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J. Mol. Biol. 207:1989;379-392.
17. van der Avoort H. G., Hull B. P., Hovi T., Pallansch M. A., Kew O. M., Crainic R., Wood D. J., Mulders M. N., van Loon A. M. Comparative study of five methods for intratypic differentiation of polioviruses. J. Clin. Microbiol. 33:1995;2562-2566.
18. van Wezel A. L., Hazendonk A. G. Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera. Intervirology. 11:1979;2-8.
19. Yoneyama T., Hagiwara A., Hara M., Shimojo H. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients. Infect. Immun. 37:1982;46-53.
20. Zell R., Stelzner A. Application of genome sequence information to the classification of bovine enteroviruses: The importance of 5′- and 3′-nontranslated regions. Virus Res. 51:1997;213-229.
21. Zuker M., Mathews D. H., Turner D. H. Barciszewski J., Clark B. F. C. Algorithms and Thermodynamics for RNA Secondary Structure Prediction: A Practical Guide in RNA Biochemistry and Biotechnology. 1999.